Terms: = Leukemia AND CRLF2, ENSG00000205755, 64109
209 results:
1. Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
van Outersterp I; Boer JM; van de Ven C; Reichert CEJ; Boeree A; Kruisinga B; de Groot-Kruseman HA; Escherich G; Sijs-Szabo A; Rijneveld AW; den Boer ML
Blood Adv; 2024 Apr; 8(8):1835-1845. PubMed ID: 38386975
[TBL] [Abstract] [Full Text] [Related]
2. Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis.
Podgorica M; Drivet E; Viken JK; Richman A; Vestbøstad J; Szodoray P; Kvam AK; Wik HS; Tjønnfjord GE; Munthe LA; Frietze S; Schjerven H
Eur J Haematol; 2024 May; 112(5):731-742. PubMed ID: 38192186
[TBL] [Abstract] [Full Text] [Related]
3. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
4. Down syndrome and leukemia: An insight into the disease biology and current treatment options.
Barwe SP; Kolb EA; Gopalakrishnapillai A
Blood Rev; 2024 Mar; 64():101154. PubMed ID: 38016838
[TBL] [Abstract] [Full Text] [Related]
5. An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia.
Mohamed SMA; Schofield P; McCalmont H; Moles E; Friedrich KH; Kavallaris M; Christ D; Bayat N; Lock RB
Int J Biol Macromol; 2024 Jan; 254(Pt 1):127596. PubMed ID: 37898250
[TBL] [Abstract] [Full Text] [Related]
6. Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.
Peroni E; Gottardi M; D'Antona L; Randi ML; Rosato A; Coltro G
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895004
[TBL] [Abstract] [Full Text] [Related]
7. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
Gupta DG; Varma N; Abdulkadir SA; Sreedharanunni S; Sachdeva MUS; Naseem S; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
Cancer; 2024 Mar; 130(5):713-726. PubMed ID: 37819686
[TBL] [Abstract] [Full Text] [Related]
8. Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets crlf2-rearranged Ph-like B-ALL.
Tian Z; Shi C; Yang G; Allen JK; Shi Q; Al-Shami A; Olson JW; Smith MG; Chang Q; Kaur J; You J; Lofton TE; Gonzalez MA; Zhang Q; Zha D; Tasian SK; Jain N; Konopleva MY; Heffernan T; Molldrem JJ
Leukemia; 2023 Oct; 37(10):2006-2016. PubMed ID: 37634013
[TBL] [Abstract] [Full Text] [Related]
9. [leukemia Genotype Analysis of Children with Acute Lymphoblastic leukemia in Yunnan Area].
Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
[TBL] [Abstract] [Full Text] [Related]
10. Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia.
Gupta DG; Varma N; Abdulkadir SA; Singh P; Sachdeva MUS; Naseem S; Siddiqui MR; Bose P; Binota J; Malhotra P; Khadwal A; Varma S
Clin Exp Med; 2023 Dec; 23(8):4539-4551. PubMed ID: 37470909
[TBL] [Abstract] [Full Text] [Related]
11. New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation.
Arwood ML; Liu Y; Harkins SK; Weinstock DM; Yang L; Stevenson KE; Plana OD; Dong J; Cirka H; Jones KL; Virtanen AT; Gupta DG; Ceas A; Lawney B; Yoda A; Leahy C; Hao M; He Z; Choi HG; Wang Y; Silvennoinen O; Hubbard SR; Zhang T; Gray NS; Li LS
Cell Chem Biol; 2023 Jun; 30(6):618-631.e12. PubMed ID: 37290440
[TBL] [Abstract] [Full Text] [Related]
12. 'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.
Gupta DG; Varma N; Sreedharanunni S; Abdulkadir SA; Naseem S; Sachdeva MUS; Binota J; Bose P; Malhotra P; Khadwal A; Varma S
Br J Cancer; 2023 Jul; 129(1):143-152. PubMed ID: 37156894
[TBL] [Abstract] [Full Text] [Related]
13. Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant-review article.
Alghandour R; Sakr DH; Shaaban Y
Ann Hematol; 2023 Jun; 102(6):1287-1300. PubMed ID: 37129698
[TBL] [Abstract] [Full Text] [Related]
14. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K; Sheikh T; Aggarwal N
Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
[TBL] [Abstract] [Full Text] [Related]
15. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
[No Abstract] [Full Text] [Related]
16. Mucin 4 protein is expressed in B-acute lymphoblastic leukemia and is restricted to BCR::ABL1-positive and BCR::ABL-like subtypes.
Gestrich CK; De Lancy SJ; Kresak A; Sinno MG; Yalley A; Pateva I; Meyerson H; Shetty S; Oduro KA
Hum Pathol; 2023 Jun; 136():75-83. PubMed ID: 37023866
[TBL] [Abstract] [Full Text] [Related]
17. Ph-like acute lymphoblastic leukemia in adults: understanding pathogenesis, improving outcomes, and future directions for therapy.
Aldoss I; Gu Z; Afkhami M; Mokhtari S; Pullarkat V
Leuk Lymphoma; 2023 Jun; 64(6):1092-1101. PubMed ID: 37021793
[TBL] [Abstract] [Full Text] [Related]
18. High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions.
Aldoss I; Afkhami M; Yang D; Gu Z; Mokhtari S; Shahani S; Pourhassan H; Agrawal V; Koller P; Arslan S; Tomasian V; Al Malki MM; Artz A; Salhotra A; Ali H; Aribi A; Sandhu KS; Ball B; Otoukesh S; Amanam I; Becker PS; Stewart FM; Curtin P; Smith E; Telatar M; Stein AS; Marcucci G; Forman SJ; Nakamura R; Pullarkat V
Am J Hematol; 2023 Jun; 98(6):848-856. PubMed ID: 36880203
[TBL] [Abstract] [Full Text] [Related]
19. Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing.
Migita NA; Jotta PY; Nascimento NPD; Vasconcelos VS; Centoducatte GL; Massirer KB; Azevedo AC; Brandalise SR; Yunes JA
Blood Adv; 2023 Jul; 7(13):2957-2971. PubMed ID: 36848637
[TBL] [Abstract] [Full Text] [Related]
20. Clinical, biological, and outcome features of P2RY8-crlf2 and crlf2 over-expression in pediatric B-cell precursor acute lymphoblastic leukemia according to the CCLG-ALL 2008 and 2018 protocol.
Wang Y; Li J; Xue TL; Tian S; Yue ZX; Liu SG; Gao C
Eur J Haematol; 2023 Jun; 110(6):669-679. PubMed ID: 36814093
[TBL] [Abstract] [Full Text] [Related]
[Next]
